Peer Review reports
From: Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
| Original Submission | ||
|---|---|---|
| 18 Dec 2023 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 26 Jan 2024 | Reviewed | Reviewer Report |
| 14 Apr 2024 | Reviewed | Reviewer Report |
| 18 Jun 2024 | Author responded | Author comments - Ala I. Sharara |
| Resubmission - Version 4 | ||
| 18 Jun 2024 | Submitted | Manuscript version 4 |
| 30 Jun 2024 | Reviewed | Reviewer Report - Zsuzsanna Kurti |
| 15 Jul 2024 | Author responded | Author comments - Ala I. Sharara |
| Resubmission - Version 5 | ||
| 15 Jul 2024 | Submitted | Manuscript version 5 |
| 22 Jul 2024 | Author responded | Author comments - Ala I. Sharara |
| Resubmission - Version 6 | ||
| 22 Jul 2024 | Submitted | Manuscript version 6 |
| Publishing | ||
| 25 Jul 2024 | Editorially accepted | |
| 4 Oct 2024 | Article published | 10.1186/s12876-024-03341-5 |
You can find further information about peer review here.